Divi's Laboratories
Indian pharmaceutical company From Wikipedia, the free encyclopedia
Divi's Laboratories Limited is an Indian multinational pharmaceutical company and producer of active pharmaceutical ingredients (APIs) and intermediates, headquartered in Hyderabad.[5][6][2][7] The company manufactures and custom synthesizes generic APIs, intermediates.[8][9] The company also manufactures and supplies nutraceutical ingredients through its subsidiary, Divi's Nutraceuticals.[10] Divi's Laboratories is India's fourth largest publicly listed pharmaceutical company by market capitalization.[11]
This article may rely excessively on sources too closely associated with the subject, potentially preventing the article from being verifiable and neutral. (March 2023) |
![]() Divi's Laboratories' logo | |
Formerly | Divi's Research Centre |
---|---|
Company type | Public |
ISIN | INE361B01024 |
Industry | Pharmaceuticals |
Founded | 12 October 1990 |
Headquarters | Divi Towers, Cyber Hills, Gachibowli, , India |
Key people | |
Products | Active Pharmaceutical Ingredients Nutraceuticals |
Services | Custom synthesis |
Revenue | ₹9,073 crore (US$1.1 billion) [1] (2022) |
₹3,683 crore (US$440 million) [1] (2022) | |
₹2,960 crore (US$350 million) [1] (2022) | |
Total assets | ₹13,374 crore (US$1.6 billion) [1] (2022) |
Total equity | ₹11,728 crore (US$1.4 billion) [1] (2022) |
Owner |
|
Number of employees | 13,884 (2020) |
Subsidiaries |
|
Website | divislabs |
Footnotes / references [1][2][3][4] |
History
The company initially started developing commercial processes for the manufacturing of APIs and intermediates. Divi's Research Centre changed its name to Divi's Laboratories Limited in 1994 to signal its intent to enter the API and intermediates manufacturing industry.[12] Following this, the company established its first Manufacturing facility in 1995 at Choutuppal, Telangana.[1] In 2002, the company's second manufacturing facility commenced operations at Chippada near Visakhapatnam.[1]
The company went public with its initial public offering (IPO) on 17 February 2003.[13][12] In 2010, the company established a research centre in Hyderabad.[1]
Facilities
The company has three manufacturing facilities and three R&D centres across India:[1]
Manufacturing
- Choutuppal Unit - Lingojigudem village, Choutuppal mandal, Yadadri Bhuvanagiri district, Telangana
- DC SEZ Unit - Lingojigudem village, Choutuppal mandal, Yadadri Bhuvanagiri district, Telangana
- Export Oriented Unit - Chippada village, Bheemunipatnam mandal, Visakhapatnam district, Andhra Pradesh
- Divi's Pharma SEZ Unit - Chippada village, Bheemunipatnam mandal, Visakhapatnam district, Andhra Pradesh
- DSN SEZ Unit - Chippada village, Bheemunipatnam mandal, Visakhapatnam district, Andhra Pradesh
- DCV SEZ Unit - Chippada village, Bheemunipatnam mandal, Visakhapatnam district, Andhra Pradesh
References
Wikiwand - on
Seamless Wikipedia browsing. On steroids.